Results of a human factors experiment of the usability and patient acceptance of a new autoinjector in patients with rheumatoid arthritis

References

• GabrielSEMichaudKEpidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseasesArthritis Res Ther200911322919519924
   PubMed Web of Science ®Google Scholar
• LugaresiAAddressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?Expert Opin Drug Deliv200969995100219637982
   PubMed Web of Science ®Google Scholar
• World Health OrganizationAdherence to Long-Term Therapies: Evidence for ActionGeneva, SwitzerlandWorld Health Organization2003
   Google Scholar
• DiMatteoMRVariations in patients’ adherence to medical recommendations: a quantitative review of 50 years of researchMed Care200442320020915076819
   PubMed Web of Science ®Google Scholar
• ArthurABKlinkhoffAVTeufelASafety of self-injection of gold and methotrexateJ Rheumatol19992623023059972962
   PubMed Web of Science ®Google Scholar
• KeiningerDCoteurGAssessment of self-injection experience in patients with rheumatoid arthritis: psychometric validation of the Self-Injection Assessment Questionnaire (SIAQ)Health Qual Life Outcomes20119221232106
   PubMed Web of Science ®Google Scholar
• DevonshireVLapierreYMacdonellRGAP Study GroupThe Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosisEur J Neurol2011181697720561039
   PubMed Web of Science ®Google Scholar
• CostelloKKennedyPScanzilloJRecognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long termMedscape J Med200810922519008986
   PubMedGoogle Scholar
• TreadawayKCutterGSalterAFactors that influence adherence with disease-modifying therapy in MSJ Neurol2009256456857619444532
   PubMed Web of Science ®Google Scholar
• MohrDCCoxDEpsteinLBoudewynATeaching patients to self-inject: pilot study of a treatment for injection anxiety and phobia in multiple sclerosis patients prescribed injectable medicationsJ Behav Ther Exp Psychiatry2002331394712389798
   PubMed Web of Science ®Google Scholar
• BerteauCSchwarzenbachFDonazzoloYEvaluation of performance, safety, subject acceptance, and compliance of a disposable autoinjector for subcutaneous injections in healthy volunteersPatient Prefer Adherence2010437938821049090
   PubMed Web of Science ®Google Scholar
• LugaresiADurastantiVGasperiniCCoSa Study GroupSafety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa studyClin Neuropharmacol200831316717218520983
   PubMed Web of Science ®Google Scholar
• WraySArmstrongRHerrmanCResults from the single-use autoinjector for self-administration of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis (MOSAIC) studyExpert Opin Drug Deliv20118121543155322032264
   PubMed Web of Science ®Google Scholar
• Lefevre-ColauMMPoiraudeauSFermanianJResponsiveness of the Cochin rheumatoid hand disability scale after surgeryRheumatology (Oxford)200140884385011511751
   PubMed Web of Science ®Google Scholar
• PoiraudeauSLefevre-ColauMMFermanianJRevelMThe ability of the Cochin rheumatoid arthritis hand functional scale to detect change during the course of diseaseArthritis Care Res200013529630314635299
   PubMed Web of Science ®Google Scholar
• TangKBeatonDEGignacMALacailleDZhangWBombardierCCanadian Arthritis Network Work Productivity GroupThe Work Instability Scale for rheumatoid arthritis predicts arthritis-related work transitions within 12 monthsArthritis Care Res (Hoboken)201062111578158720521332
   PubMed Web of Science ®Google Scholar
• PoiraudeauSLefevre-ColauMMFermanianJMayoux-BenhamouMARevelMQualités métrologiques de l’indice d’incapacité fonctionnelle de Cochin adapté à la main rhumatoïdeAnn Réadaptation Med Phys200043106115 French
   Google Scholar
• JawaheerDOlsenJLahiffMQUEST-RAGender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA StudyClin Exp Rheumatol201028445446120810033
   PubMed Web of Science ®Google Scholar
• RossiniMMaddali BongiSLa MontagnaGVitamin D deficiency in rheumatoid arthritis: prevalence, determinants and associations with disease activity and disabilityArthritis Res Ther2010126R21621114806
   PubMed Web of Science ®Google Scholar
• DahlgrenJVeimoDJohanssonLBechIPatient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label user survey of everyday useCurr Med Res Opin20072371649165517559757
   PubMed Web of Science ®Google Scholar
• FuchsGSMikkelsenSKnudsenTKKappelgaardAMEase of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability testClin Ther200931122906291420110030
   PubMed Web of Science ®Google Scholar
• Verdun di CantognoERussellSSnowTUnderstanding and meeting injection device needs in multiple sclerosis: a survey of patient attitudes and practicesPatient Prefer Adherence2011517318021573048
   PubMed Web of Science ®Google Scholar
• PhillipsJTFoxEGraingerWTuccilloDLiuSDeykinAAn open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjectsBMC Neurol20111112621999176
   PubMed Web of Science ®Google Scholar
• Hey-HadaviJPleilADeebLCEase of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: a multicenter, 2-month, single-arm, open-label clinical trial in patient-caregiver dyadsClin Ther201032122036204721118739
   PubMed Web of Science ®Google Scholar
• PrabhakaranSSweetASelf-administration of subcutaneous depot medroxyprogesterone acetate for contraception: feasibility and acceptabilityContraception201285545345722079605
   PubMed Web of Science ®Google Scholar
• GreenJKleinmanLCieslaGHuangJWintfeldNRevickiDSubcutaneous injection survey: psychometric evaluation of a treatment satisfaction instrument associated with a novel HIV medicationHIV Clin Trials20023538739512407488
   PubMedGoogle Scholar
• CohenCHellingerJJohnsonMPatient acceptance of self-injected enfuvirtide at 8 and 24 weeksHIV Clin Trials20034534735714583851
   PubMed Web of Science ®Google Scholar
• TierneyPASamuelDPatelKSThomasDMAudit of patient acceptance of nasal surgery as a day case procedureBr J Clin Pract19965073573599015905
   PubMedGoogle Scholar
• DevonshireVArbizuTBorreBPatient-rated suitability of a novel electronic device for self-injection of subcutaneous interferon beta-1a in relapsing multiple sclerosis: an international, single-arm, multicentre, Phase IIIb studyBMC Neurol2010102820433746
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration [webpage on the Internet]Draft guidance for industry and Food and Drug Administration staff: applying human factors and usability engineering to optimize medical device designSilver Spring, MDUS Food and Drug Administration2011Available from: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm259748.htmAccessed March 12, 2013
   Google Scholar